Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fausto Petrelli

Showing results (101-110 of 304) with videos related to

Pageof 31
Sort By:
JCO Oncology Practice|January 9, 2026
Subcutaneous Immunotherapy in Cancer: Where We Are Now, What It Changes, and What to Watch NextFausto Petrelli, Alessandro Iaculli, Alberto Zambelli, et al.
Scientific Reports|January 21, 2022
Survival benefit with adjuvant chemotherapy in stage III microsatellite-high/deficient mismatch repair colon cancer: a systematic review and meta-analysisGianluca Tomasello, Michele Ghidini, Barbara Galassi, et al.
World Journal of Methodology|May 24, 2021
Tocilizumab as treatment for COVID-19: A systematic review and meta-analysisFausto Petrelli, Sara Cherri, Michele Ghidini, et al.
Breast Cancer Research and Treatment|November 3, 2016
Platinum salts in advanced breast cancer: a systematic review and meta-analysis of randomized clinical trialsFausto Petrelli, Sandro Barni, Giacomo Bregni, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 3, 2017
Disease-free survival is not a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a systematic review of randomized trialsFausto Petrelli, Gianluca Tomasello, Michele Ghidini, et al.
Breast Cancer Research and Treatment|July 18, 2013
Five or more years of adjuvant endocrine therapy in breast cancer: a meta-analysis of published randomised trialsFausto Petrelli, Andrea Coinu, Mary Cabiddu, et al.
International Urology and Nephrology|April 21, 2026
Early versus deferred immunotherapy in urothelial carcinoma: a review of evidence and post-progression survivalFausto Petrelli, Antonio Ghidini, Ivano Vavassori, et al.
Journal of Gastrointestinal Oncology|March 11, 2017
Pathologic complete response and disease-free survival are not surrogate endpoints for 5-year survival in rectal cancer: an analysis of 22 randomized trialsFausto Petrelli, Karen Borgonovo, Mary Cabiddu, et al.
Reviews on Recent Clinical Trials|July 18, 2013
Cetuximab/irinotecan-chemotherapy in KRAS wild-type pretreated metastatic colorectal cancer: a pooled analysis and review of literatureSandro Barni, Mara Ghilardi, Karen Borgonovo, et al.
Clinical Genitourinary Cancer|March 5, 2014
Radical prostatectomy or radiotherapy in high-risk prostate cancer: a systematic review and metaanalysisFausto Petrelli, Ivano Vavassori, Andrea Coinu, et al.
Pageof 31

Showing results (101-110 of 304) with videos related to

Sort By:
Pageof 31
JCO Oncology Practice|January 9, 2026
Subcutaneous Immunotherapy in Cancer: Where We Are Now, What It Changes, and What to Watch NextFausto Petrelli, Alessandro Iaculli, Alberto Zambelli, et al.
Scientific Reports|January 21, 2022
Survival benefit with adjuvant chemotherapy in stage III microsatellite-high/deficient mismatch repair colon cancer: a systematic review and meta-analysisGianluca Tomasello, Michele Ghidini, Barbara Galassi, et al.
World Journal of Methodology|May 24, 2021
Tocilizumab as treatment for COVID-19: A systematic review and meta-analysisFausto Petrelli, Sara Cherri, Michele Ghidini, et al.
Breast Cancer Research and Treatment|November 3, 2016
Platinum salts in advanced breast cancer: a systematic review and meta-analysis of randomized clinical trialsFausto Petrelli, Sandro Barni, Giacomo Bregni, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 3, 2017
Disease-free survival is not a surrogate endpoint for overall survival in adjuvant trials of pancreatic cancer: a systematic review of randomized trialsFausto Petrelli, Gianluca Tomasello, Michele Ghidini, et al.
Breast Cancer Research and Treatment|July 18, 2013
Five or more years of adjuvant endocrine therapy in breast cancer: a meta-analysis of published randomised trialsFausto Petrelli, Andrea Coinu, Mary Cabiddu, et al.
International Urology and Nephrology|April 21, 2026
Early versus deferred immunotherapy in urothelial carcinoma: a review of evidence and post-progression survivalFausto Petrelli, Antonio Ghidini, Ivano Vavassori, et al.
Journal of Gastrointestinal Oncology|March 11, 2017
Pathologic complete response and disease-free survival are not surrogate endpoints for 5-year survival in rectal cancer: an analysis of 22 randomized trialsFausto Petrelli, Karen Borgonovo, Mary Cabiddu, et al.
Reviews on Recent Clinical Trials|July 18, 2013
Cetuximab/irinotecan-chemotherapy in KRAS wild-type pretreated metastatic colorectal cancer: a pooled analysis and review of literatureSandro Barni, Mara Ghilardi, Karen Borgonovo, et al.
Clinical Genitourinary Cancer|March 5, 2014
Radical prostatectomy or radiotherapy in high-risk prostate cancer: a systematic review and metaanalysisFausto Petrelli, Ivano Vavassori, Andrea Coinu, et al.
Pageof 31